Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03327142 |
Other study ID # |
AdrenalG EUS-Study |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
March 29, 2017 |
Last updated |
October 30, 2017 |
Start date |
December 8, 2015 |
Est. completion date |
April 30, 2016 |
Study information
Verified date |
August 2017 |
Source |
Hospital Universitari de Bellvitge |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
To analyze the diagnostic performance, safety, impact on clinical management, predictors of
malignancy and cyto-pathological correlation of the EUS-FNA with AG. National multicenter
retrospective study. Mailing-SEED partners. Participation: 17 Spanish centers. Inclusion
period: April / 2003 to April / 2016 Inclusion criteria: All AG (Left / Right) punctured by
EUS.
A review of 205 EUS-FNA of AG in 200 patients is included.
Description:
INTRODUCTION: The EUS has proven useful in the study and evaluation of the adrenal gland (AG)
by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA), in both the left and right
glands.
OBJECTIVE: To analyze the diagnostic performance, safety, impact on clinical management,
predictors of malignancy and cyto-pathological correlation of the EUS-FNA with AG.
MATERIALS AND METHODS: National multicenter retrospective study. Mailing-SEED partners.
Participation: 17 Spanish centers. Inclusion period: April / 2003 to April / 2016 Inclusion
criteria: All AG (Left / Right) punctured by EUS. Variables reviewed: Demographic
characteristics, clinical, extension studies, USE and pathological data. Comparison between
variables; and estimation of multivariate logistic model for cytology, mortality and
therapeutic change.